|Credit: Bruce Booth|
As a macro point, these data reflect the intuitive sense we have of recruiting talent from other regions into Boston: with regards to R&D teams, prior Pharma hubs are shrinking rapidly while Boston is growing. We’ve even recruited a few sun-loving San Diego biopharma vets to move to the Boston market recently.Readers are probably quite tired of me pounding on this point (and I should limit myself to one of these posts about every month or so.) What does this mean? I'll take a couple of stabs:
- If you are a graduate student or postdoctoral fellow who intends to work in biopharma, picking an institution that has a healthy pipeline into universities or companies in the Bay Area or Boston would be key.
- Although I suspect job security would be no greater than anywhere else, the likelihood of moving would be lower for scientists who live in these areas.
- Economic development organizations should consider other new, exciting fields to attempt to start local clusters long before they consider trying to start a biopharma cluster. What is your town going to do that Seattle hasn't done?